Global Inosine Pranobex Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.
According to our (Global Info Research) latest study, the global Inosine Pranobex market size was valued at USD 206.8 million in 2022 and is forecast to a readjusted size of USD 239.3 million by 2029 with a CAGR of 2.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Inosine Pranobex key players include Newport Pharmaceuticals, Gedeon Richter, etc. Global top two manufacturers hold a share about 50%.
Europe is the largest market, with a share about 55%, followed by North America and Japan, both have a share about 20 percent. 
In terms of product, Tablet is the largest segment, with a share about 70%. And in terms of application, the largest application is Antiviral, followed by Immunomodulation, etc.
This report is a detailed and comprehensive analysis for global Inosine Pranobex market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Inosine Pranobex market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Inosine Pranobex market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Inosine Pranobex market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Inosine Pranobex market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Inosine Pranobex
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Inosine Pranobex market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Newport Pharmaceuticals, Gedeon Richter, Mochida, Sanofi and Andr�maco, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Inosine Pranobex market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Tablet
    Syrup
Market segment by Application
    Immunomodulation
    Antiviral
    Other
Major players covered
    Newport Pharmaceuticals
    Gedeon Richter
    Mochida
    Sanofi
    Andr�maco
    Yung Shin
    Alfasigma S.p.A.
    Polfarmex
    Sanfer
    Meprofarm
    Novell Pharmaceutical
    Aflofarm
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Inosine Pranobex product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Inosine Pranobex, with price, sales, revenue and global market share of Inosine Pranobex from 2018 to 2023.
Chapter 3, the Inosine Pranobex competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Inosine Pranobex breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Inosine Pranobex market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Inosine Pranobex.
Chapter 14 and 15, to describe Inosine Pranobex sales channel, distributors, customers, research findings and conclusion.